PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,498 | +114.0% | 6,142 | +123.7% | 0.00% | – |
| Q2 2023 | $49,754 | +32.2% | 2,746 | +94.1% | 0.00% | – |
| Q1 2023 | $37,635 | +246.4% | 1,415 | +163.5% | 0.00% | – |
| Q4 2022 | $10,866 | +262.2% | 537 | +300.7% | 0.00% | – |
| Q3 2022 | $3,000 | – | 134 | +294.1% | 0.00% | – |
| Q2 2022 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 34 | +100.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 17 | -88.7% | 0.00% | – |
| Q2 2021 | $4,000 | -66.7% | 150 | -50.0% | 0.00% | – |
| Q1 2021 | $12,000 | -45.5% | 300 | -68.4% | 0.00% | – |
| Q4 2020 | $22,000 | -18.5% | 950 | -19.1% | 0.00% | – |
| Q3 2020 | $27,000 | -53.4% | 1,175 | -34.7% | 0.00% | – |
| Q2 2020 | $58,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |